本文關(guān)鍵詞：p53調(diào)控腫瘤細(xì)胞自噬以及化療耐藥的實(shí)驗(yàn)研究，由筆耕文化傳播整理發(fā)布。

評(píng)論   全文閱讀： FullText | PDF

文獻(xiàn)標(biāo)引:趙萬(wàn)忠 程凱 王曉紅 花義同 許乘鳳 姜京汝 楊振林.補(bǔ)骨脂素逆轉(zhuǎn)腫瘤細(xì)胞多藥耐藥的進(jìn)展[J/CD].中華臨床醫(yī)師雜志：電子版,2016,10(7):1012-1015.

參考文獻(xiàn):
[1] 王萌, 陳建偉, 李祥. 明黨參根皮中5種呋喃香豆素類(lèi)成分的體外抗腫瘤活性[J]. 中國(guó)實(shí)驗(yàn)方劑學(xué)雜志, 2012, 18(6): 203-205.
[2] Leslie EM, Deeley RG, Cole SP. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP(ABCG2) in tissue defense[J]. Toxicol Appl Pharmacol, 2005, 204(3): 216-237.
[3] 顧卓偉, 狄文. 應(yīng)用ABC轉(zhuǎn)運(yùn)蛋白抑制劑治療腫瘤化療耐藥的現(xiàn)狀與對(duì)策[J]. 現(xiàn)代婦產(chǎn)科進(jìn)展, 2015 (4): 299-302.
[4] 張孟仁. 中西醫(yī)結(jié)合治療乳腺癌的優(yōu)勢(shì)[J]. 環(huán)球中醫(yī)藥, 2012,5(12): 937-939.
[5] Wang EJ, Casciano CN, Clement RP, et al. Inhibition of P-glycoprotein transport function by grapefruit juice psoralen[J]. Pharm Res, 2001, 18(4): 432-438.
[6] Wang X, Zhang X, Huang X, et al. The drug-drug interaction of sorafenib mediated by P-glycoprotein and CYP3A4[J]. Xenobiotica, 2015: 1-8.
[7] 任玉偉, 宿華威. Bcl-2基因家族研究進(jìn)展[J]. 大連醫(yī)科大學(xué)學(xué)報(bào), 2015, 37(2): 202-205.
[8] Jiang Z, Xiong J. Induction of apoptosis in human hepatocarcinoma SMMC-7721 cells in vitro by psoralen from Psoralea corylifolia [J]. Cell Biochem Biophys, 2014, 70(2): 1075-1081.
[9] Sun SJ, Zhao WJ, Xiang Y, et al.[Photochemotherapy with psoralen and ultraviolet A induced apoptosis of NB4 cells and its effects on caspase-8 and caspase-8 protein expressions][J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2013, 33(4): 502-505.
[10] 譚敏, 孫靜, 趙虹, 等. 補(bǔ)骨脂素對(duì)乳腺癌MCF-7和MDA-MB-231細(xì)胞體外作用的比較研究[J]. 廣州中醫(yī)藥大學(xué)學(xué)報(bào), 2009, 26(4): 359-362.
[11] 蔡宇, 楊燕霞, 梁少玲, 等. 補(bǔ)骨脂素對(duì)乳腺癌多藥耐藥細(xì)胞株Bcl-2基因蛋白表達(dá)的影響[J]. 中藥材, 2004, 27(11): 855-856.
[12] 閆毓秀, 張淑萍, 滑靜. p53基因研究進(jìn)展[J]. 北京農(nóng)學(xué)院學(xué)報(bào), 2009, 24(2): 74-77.
[13] 孔德娟. p53調(diào)控腫瘤細(xì)胞自噬以及化療耐藥的實(shí)驗(yàn)研究[D]. 吉林大學(xué), 2014.
[14] Cimino GD, Gamper HB, Isaacs ST, et al. Psoralens as photoactive probes of nucleic acid structure and function: organic chemistry, photochemistry, and biochemistry[J]. Annu Rev Biochem, 1985, 54: 1151-1193.
[15] Zhou BR, Xu Y, Wu D, et al. Ginsenoside Rg1 protects human fibroblasts against psoralen- and UVA-induced premature senescence through a telomeric mechanism[J]. Arch Dermatol Res, 2012, 304(3): 223-228.
[16] El-Domyati M, Moftah NH, Nasif GA, et al. Evaluation of apoptosis regulatory proteins in response to PUVA therapy for psoriasis[J]. Photodermatol Photoimmunol Photomed, 2013, 29(1): 18-26.
[17] 謝黎黎, 李俊, 顧康生. 乳腺癌Her-2基因基礎(chǔ)與臨床研究進(jìn)展[J]. 安徽醫(yī)藥, 2009, 13(10): 1160-1161.
[18] 劉丹. Erbin對(duì)Her2陽(yáng)性乳腺腺癌細(xì)胞的遷移能力及赫賽汀耐藥的影響及相關(guān)機(jī)制研究[D]. 河北醫(yī)科大學(xué), 2013.
[19] 蓋曉東, 歷春, 李倩, 等. 柴胡皂苷在體外對(duì)人白血病細(xì)胞株K562/ADM多藥耐藥性的逆轉(zhuǎn)作用[J]. 中國(guó)病理生理雜志, 2012, 28(1): 76-80.
[20] Xia W, Gooden D, Liu L, et al. Photo-activated psoralen binds the ErbB2 catalytic kinase domain, blocking ErbB2 signaling and triggering tumor cell apoptosis[J]. PLoS One, 2014, 9(2): e88983.
[21] Liu B, Staren ED, Iwamura T, et al. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma[J]. J Surg Res, 2001, 99(2): 179-186.
[22] Eun JS, Choi BH, Park JA, et al. Open channel block of hKv1. 5 by psoralen from Heracleum moellendorffii Hance[J]. Arch Pharm Res, 2005, 28(3): 269-273.
[23] 陳超, 蔡天革, 張榮華, 等. 6種中藥活性成分對(duì)K562/ADM耐藥性逆轉(zhuǎn)及P27和P170蛋白表達(dá)影響[J]. 中成藥, 2014, 36(1): 1-4.
[24] 劉換新, 吳曉霞, 張燕, 等. 鉀離子通道蛋白Kir2.1/KCNJ2及多藥耐藥蛋白MRP1/ABCC1在小細(xì)胞肺癌中的表達(dá)及相關(guān)性[J]. 中國(guó)病理生理雜志, 2013, 29(11): 1940-1945.
[25] Liu J, Xu P, Collins C, et al. HIV-1 Tat protein increases microglial outward K(+) current and resultant neurotoxic activity[J]. PLoS One, 2013, 8(5): e64904.
[26] Xu R, Cao M, Wu X, et al. Kv1. 3 channels as a potential target for immunomodulation of CD4+ CD28null T cells in patients with acute coronary syndrome[J]. Clin Immunol, 2012, 142(2): 209-217.
[27] Leanza L, Trentin L, Becker KA, et al. Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1. 3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia[J]. Leukemia, 2013, 27(8): 1782-1785.
[28] Leanza L, Henry B, Sassi N, et al. Inhibitors of mitochondrial Kv1. 3 channels induce Bax/Bak-independent death of cancer cells[J]. EMBO Mol Med, 2012, 4(7): 577-593.

  本文關(guān)鍵詞：p53調(diào)控腫瘤細(xì)胞自噬以及化療耐藥的實(shí)驗(yàn)研究，由筆耕文化傳播整理發(fā)布。